ArticleJournal of experimental orthopaedics2025
The use of biocomposite vented anchors for arthroscopic remplissage allows for better bony ingrowth than peek vented anchors: A volumetric CT study of 85 anchors.
Article in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The use of biocomposite vented anchors for arthroscopic remplissage allows for better bony ingrowth than peek vented anchors: A volumetric CT study of 85 anchors.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate whether the use of polyetheretherketone (PEEK) or biocomposite vented anchors has any impact on bony ingrowth inside the anchor or implant-related osteolysis after implantation during remplissage for Hill-Sachs defects (HSD) in patients with shoulder instability. Methods: Prospective cohort study with a minimum of 24 months follow-up (mean follow-up 3.11[SD = 0.67] years). Forty-nine subjects (43 males and 6 females; mean age 27.6[SD:9.22] years) with HSD undergoing remplissage were evaluated with a CT performed at a mean of 14.7[4,4] months after surgery. The procedures were performed in two cohorts: in the first, 44 anchors (4.5 mm Healicoil PEEK) were used in 26 subjects. In the second, 41 anchors (4.75 mm Healicoil Regenesorb biocomposite) were used in 21 subjects. A computed tomography evaluation of the volume of the bone defects and the degree of bony ingrowth was made. Results: Preoperatively both cohorts were homogenous. The biocomposite anchors showed better bony ingrowth than the PEEK anchors ( Conclusion: Biocomposite vented anchors for remplissage favours bony ingrowth and lower the incidence of osteolysis and defect formation when compared to PEEK anchors with similar clinical outcomes. Level of Evidence: Level II, prospective cohort study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.